Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Special Drug Use Investigation for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment

NCT01428531 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01428531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01428531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Special Drug Use Investigation for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
January 31, 2012
Completion date
June 30, 2015
Enrollment
200 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ataxia